?1,2-Dihydro Exemestane | High-Purity Anticancer Intermediate & API Synthesis Reagent? ????

?? ?Product Overview?

1,2-Dihydro Exemestane is a ?pharmaceutically active steroid derivative? critical for synthesizing anticancer APIs, particularly aromatase inhibitors used in hormone-dependent cancer therapies?12. As a ?key intermediate?, it enables precise enzymatic modifications for oncology drug development, including breast and ovarian cancer treatments?14. Its structural stability supports large-scale industrial synthesis and R&D applications?35.

? ?Key Advantages?

?? ?Applications?

• ?Anticancer Drug Synthesis?

  : Core precursor for ?exemestane? and other aromatase inhibitors?.

• ?Pharmaceutical Research?

  : Reference standard for metabolic pathway studies?45.

• ?Industrial Biocatalysis?

  : Substrate for enzyme-mediated steroid transformations?13.

• ?Oncology Formulations?

  : Supports targeted therapies for hormone-sensitive cancers?12.

?? ?Quality Certifications?

• ?GMP-Compliant Production?

  : ISO 9001-certified facilities?15.

• ?Residual Solvents?

  : <50 ppm (ICH Q3C compliant)?15.

• ?Multi-Method Validation?

  : NMR, FTIR, and LC-MS batch testing?12.

?? ?Market Trends?

The ?global oncology intermediates market? is projected to grow at ?7.1% CAGR through 2030?, fueled by rising demand for precision cancer therapies?34. Aromatase inhibitors like exemestane dominate ?22% of the hormone therapy sector?, underscoring this intermediate’s commercial relevance?12.